Eddit

Version vom 30. Mai 2020, 07:09 Uhr

• Further reading

32362782 2020. Aktuelle Informationen zu COVID-19 auf einer Plattform ? zeitschriftenübergreifend

• Unproven ideas
• Reviews on covid19 disease

32330209 ä. A precision medicine approach to managing 2019 novel coronavirus pneumonia
32278960 2020. COVID-19 from veterinary medicine and one health perspectives: What animal coronaviruses have taught us
32345483 ä. CCOVID-19 with Pulmonary Involvement. An Autoimmune Disease of Known Cause
32334862 ä. COVID-19�: caract�ristiques cliniques, biologiques et radiologiques chez l?adulte, la femme enceinte et l?enfant Une mise au point au c?ur de la pand�mie
32336927 ä. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Emergence, History, Basic and Clinical Aspects

• Clinical guidelines and advice

32327870 ä. Recomendaciones sobre el tratamiento antitromb�tico durante la pandemia COVID-19 Posicionamiento del Grupo de Trabajo de Trombosis Cardiovascular de la Sociedad Espa�ola de Cardiolog�a

• Respiration mgmt

• Diagnosis (Laboratory)

C7187661 ä. Group Testing for SARS-CoV-2: Forward to the Past?
32329979 2020. COVID-19 rapid antibody cassette point of care tests: practical considerations

32270436 ä. Detection of serum IgM and IgG for COVID-19 diagnosis

• Diagnosis (Lung CT, Sonography)

32321099 ä. COVID-19 - Computed tomography findings in two patients in Petr�polis, Rio de Janeiro, Brazil
32267461 ä. Chest radiography and computed tomography findings from a Brazilian patient with COVID-19 pneumonia
32215898 2020. CT-Morphologie von COVID-19: Fallbeispiel und Literaturubersicht
32193883 2020. CT appearance of severe, laboratory-proven coronavirus disease 2019 (COVID-19) in a Caucasian patient in Berlin, Germany

• Diagnosis (other modalities)

• Structure of covid19

32269081 2020. Phylogenetic network analysis of SARS-CoV-2 genomes
32009228 2020. Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission

• Target binding and uptake

32165541 2020. Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells
32364961 2020. Severe respiratory SARS-CoV2 infection: Does ACE2 receptor matter?

• Cytopathic effects

• Secretion and shedding

32304647 2020. SARS-CoV-2 shedding and infectivity
32304646 ä. SARS-CoV-2 shedding and infectivity ? Authors reply

• Innate sensing

• Immunology

32292530 2020. Respiratory diseases, allergy and COVID-19 infection. First news from Wuhan

• Cytokine storm, hemophagocytic lymphohistiocytosis, macrophage activation syndrome

• Pathobiology

32326988 ä. Lactose Dehydrogenase in Patients with Severe COVID-19: A Meta-Analysis of Retrospective Study
32339247 ä. Does apolipoprotein E genotype predict COVID-19 severity?

• Disease Models

32303993 ä. Recapitulation of SARS-CoV-2 infection and cholangiocyte damage with human liver ductal organoids

• Similar diseases and pathomechanisms

32342879 ä. COVID-19 and radiation induced pneumonitis: overlapping clinical features of different diseases

• Early symptoms

• Systemic disease, any manifestations

32222804 ä. Arthralgia as an initial presentation of COVID-19: observation

• Co-Infection

32192233 2020. Co-infection with SARS-CoV-2 and Human Metapneumovirus
32170625 ä. Co-infections of SARS-CoV-2 with multiple common respiratory pathogens in infected patients

• ARDS

• Pulmonary embolism, coagulation

32356640 2020. SARS-CoV-2 pneumonia and pulmonary embolism in a 66-year-old female
32329980 2020. SARS-CoV-2 infection masquerading as a possible pulmonary embolism
32351657 ä. Arterial and venous abdominal thrombosis in a 79-year-old woman with COVID-19 pneumonia

• Hematology

32294340 ä. Immune Thrombocytopenic Purpura in a Patient with Covid-19

• Microvascular

• Heart

32372844 ä. COVID-19 y tratamiento guiado con tests de diagn�stico bioqu�micos y moleculares para reducir el da�o cardiaco y la cardiotoxicidad
32355394 ä. COVID-19 y shock cardiog�nico: diferentes formas de presentaci�n cardiovascular con alta mortalidad
32345547 ä. Fulminant myocarditis due to COVID-19
32267110 2020. COVID-19 et maladies cardiovasculaires

• Neurology, ophthalmology, orl

32329044 2020. Complicaciones neurologicas por coronavirus y COVID-19
32359804 ä. Covid-19 and Guillain-Barr� syndrome: More than a coincidence!
32334841 ä. COVID-19 may induce Guillain-Barr� syndrome
32246403 ä. The brain, another potential target organ, needs early protection from SARS-CoV-2 neuroinvasion

• Dermatology

• Gastroenterology, hepatology

32328338 2020. Anal swab findings in an infant with COVID?19
32356641 2020. Addressing multiple gastroenterological aspects of COVID-19
32250094 2020. Gastrointestinal symptoms as the first, atypical indication of severe acute respiratory syndrome coronavirus 2 infection
32343593 2020. COVID-19, coronavirus, SARS-CoV-2 and the small bowel
32376072 ä. Beware: Gastrointestinal symptoms can be a manifestation of COVID-19

• Kidney, urology

32362571 2020. SARS-CoV-2 and the testis: similarity with other viruses and routes of infection

• Risk and special populations

C7129713 ä. Coronavirus: la emergencia geri�trica de 2020 Documento conjunto de la Secci�n de Cardiolog�a Geri�trica de la Sociedad Espa�ola de Cardiolog�a y la Sociedad Espa�ola de Geriatr�a y Gerontolog�a
C7151242 ä. Controversy regarding ACE inhibitors / ARBs in Covid-19
32331829 ä. Smoking and coronavirus disease 2019 (COVID-19)
32362357 ä. Patients with MS treated with immunosuppressive agents: Across the COVID-19 spectrum
32314010 ä. Coronavirus Disease 19 (COVID-19) complicated with pneumonia in a patient with rheumatoid arthritis receiving conventional disease-modifying antirheumatic drugs
32346493 ä. Clinical presentations and outcomes of SARS-CoV-2 infected pneumonia in pregnant women and health status of their neonates

• The morbid survivor
• Case reports

• Case series

32146694 ä. Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China

• Registries

• Trials
• Candidate Compounds Covid19

32239125 2020. Remdesivir, la esperanza antiviral frente al SARS-CoV-2
32256547 2020. Clinical trials on drug repositioning for COVID-19 treatment
32267301 ä. Driving forces for COVID-19 clinical trials using chloroquine: the need to choose the right research questions and outcomes
32232552 ä. Coronavirus disease 2019 (COVID-19) and anti-rheumatic drugs
32124179 ä. Clinical trials for the treatment of Coronavirus disease 2019 (COVID-19): A rapid response to urgent need

• Other routes of infection

32291098 ä. Assessing Viral Shedding and Infectivity of Tears in Coronavirus Disease 2019 (COVID-19) Patients

• Biophysics of aerosols

• Passive protective equipment

• Running your hospital

32372843 ä. Telecardiolog�a en tiempos de la pandemia COVID-19
32338017 2020. COVID-19 and the digestive system: protection and management during the SARS-CoV-2 pandemic
32316737 2020. Resumption of activity in gastroenterology departments Recommendations by SEPD, AEEH, GETECCU and AEG
32202911 2020. Recommendations by the SEPD and AEG, both in general and on the operation of gastrointestinal endoscopy and gastroenterology units, concerning the current SARS-CoV-2 pandemic (March, 18)
32329046 2020. Documento EMCAM (Esclerosis Multiple Comunidad Autonoma de Madrid) para el manejo de pacientes con esclerosis multiple durante la pandemia de SARS-CoV-2
32329045 2020. Herramientas de salud digital para superar la brecha de atencion en epilepsia antes, durante y despues de la pandemia de COVID-19
32303331 2020. Covid-19, the pandemic war: Implication for neurologists
32354651 ä. Guidance for the care of neuromuscular patients during the COVID-19 pandemic outbreak from the French Rare Health Care for Neuromuscular Diseases Network
32320999 2020. CHALLENGES IN THE FIGHT AGAINST THE COVID-19 PANDEMIC IN UNIVERSITY HOSPITALS

32292260 2020. Guidelines for dental care provision during the COVID-19 pandemic
32341229 2020. Saudi association for the study of liver diseases and transplantation position statement on liver transplantation during the COVID-19 pandemic
32343342 ä. The COVID-19 Global Pandemic: Implications for People With Schizophrenia and Related Disorders
32345478 ä. Is schizophrenia research relevant during the COVID-19 pandemic?
32349886 ä. Long-acting injectable antipsychotics treatment during COVID-19 pandemic ? A new challenge
32299718 ä. Ecosystem approaches to the risk for schizophrenia
32327314 ä. COVID-19, mobile health and serious mental illness

• Mental aspects of health professionals

• Socio-psychiatric aspects of the status hygienicus

• Avoiding clinical medicine in other diseases

32283124 ä. Reduction in ST-Segment Elevation Cardiac Catheterization Laboratory Activations in the United States during COVID-19 Pandemic

• Occupational medicine, workplace security and status hygienicus

• Economic aspects of the status hygienicus

32242087 ä. What the stock market tells us about the post-COVID-19 world
32313382 ä. Can Global Pharmaceutical Supply Chains Scale Up Sustainably for the COVID-19 Crisis?
32313383 2020. A brave new world: Lessons from the COVID-19 pandemic for transitioning to sustainable supply and production

• Educational aspects of the status hygienicus

32313309 ä. Education and the COVID-19 pandemic
32302818 2020. Impact Of Sars-Cov-2 And Its Reverberation In Global Higher Education And Mental Health

• Host, vector, one health, atmospheric aspects

32300261 2020. Severe air pollution events not avoided by reduced anthropogenic activities during COVID-19 outbreak
32333993 ä. Does the pathogenesis of SAR-CoV-2 virus decrease at high-altitude?

• Origin of Covid19

• Epidemiology

32267109 2020. Coronavirus et COVID-19 : le point sur une pandemie galopante
32294667 ä. Translating transmissibility measures into recommendations for coronavirus prevention
32236385 ä. Outbreak investigation in cargo ship in times of COVID-19 crisis, Port of Santos, Brazil
32320998 ä. COVID-19 in Brazil: advantages of a socialized unified health system and preparation to contain cases
32215461 ä. The value of mitigating epidemic peaks of COVID-19 for more effective public health responses

32373394 ä. Using the contact network model and Metropolis-Hastings sampling to reconstruct the COVID-19 spread on the ?Diamond Princess?
32292631 ä. The inflection point about COVID-19 may have passed
32288968 2020. A data driven time-dependent transmission rate for tracking an epidemic: a case study of 2019-nCoV
32296594 ä. A systematic approach is needed to contain COVID-19 globally
32210236 2020. Epidemiological data from the COVID-19 outbreak, real-time case information

• Remission, recurrence and persistence

32308203 2020. Patients with respiratory symptoms are at greater risk of COVID-19 transmission

• Failure of executive measures

• Failure of politics and public health guidance

• Political abuse of Covid19

32203324 ä. COVID-19 and the crisis of national development

• Lost people

• Lost civilization

• History of covid19 exploration

32088858 ä. Puzzle of highly pathogenic human coronaviruses (2019-nCoV)

• misc.

32361911 ä. Single-cell transcriptome analysis of the novel coronavirus (SARS-CoV-2) associated gene ACE2 expression in normal and non-obstructive azoospermia (NOA) human male testes

• Research tools

• PrePrint scene'''
• prelights

• from the ads
• [lifechemicals.com antiviral candidate drugs]
• [biomol.com assays cytokines general spectrum]
• [labospace.com custom single probe assay 400 possible cytokines and so on]
• [codexdna.com dna synthesis]
• [eclipsebio.com around rna]
• [btbemulsions.com freud adjuvant kit]
• [biophysics.com div.]
• [molecular-machines.com microdissection]
• Current state of coviki.org